Cocrystal Pharma Stock Target Price

COCP Stock  USD 1.40  0.10  6.67%   
Cocrystal Pharma fundamentals help investors to digest information that contributes to Cocrystal Pharma's financial success or failures. It also enables traders to predict the movement of Cocrystal Stock. The fundamental analysis module provides a way to measure Cocrystal Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cocrystal Pharma stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cocrystal Target Price Analysis

Current Cocrystal Pharma Target Price

    
  8.0  
Most of Cocrystal Pharma's fundamental indicators, such as Target Price, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cocrystal Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Cocrystal Target Price Driver Correlations

Understanding the fundamental principles of building solid financial models for Cocrystal Pharma is extremely important. It helps to project a fair market value of Cocrystal Stock properly, considering its historical fundamentals such as Target Price. Since Cocrystal Pharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cocrystal Pharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cocrystal Pharma's interrelated accounts and indicators.
0.570.010.130.28-0.110.77-0.080.550.3-0.28-0.110.640.310.62-0.50.930.080.490.610.03-0.190.030.010.01-0.07-0.190.29-0.160.02
0.57-0.21-0.280.520.53-0.070.120.67-0.23-0.240.150.48-0.330.16-0.530.520.620.880.83-0.45-0.72-0.45-0.49-0.17-0.580.040.040.080.15
0.01-0.210.790.09-0.690.21-0.970.160.34-0.20.370.370.50.00.4-0.3-0.67-0.280.180.60.570.60.580.480.61-0.70.6-0.97-0.39
0.13-0.280.790.0-0.910.4-0.780.210.54-0.14-0.060.280.780.140.57-0.07-0.9-0.350.190.920.850.920.90.580.91-0.740.87-0.78-0.12
0.280.520.090.00.21-0.07-0.080.43-0.16-0.29-0.110.03-0.160.01-0.030.250.210.680.670.0-0.30.0-0.02-0.09-0.150.15-0.05-0.15-0.07
-0.110.53-0.69-0.910.21-0.580.70.01-0.60.140.15-0.21-0.83-0.19-0.510.030.930.60.11-0.89-0.92-0.89-0.87-0.67-0.930.58-0.710.660.05
0.77-0.070.210.4-0.07-0.58-0.240.170.56-0.18-0.240.430.650.62-0.180.72-0.39-0.110.10.40.350.410.40.230.39-0.280.34-0.28-0.06
-0.080.12-0.97-0.78-0.080.7-0.24-0.22-0.320.3-0.35-0.47-0.49-0.01-0.330.240.620.25-0.24-0.56-0.52-0.57-0.52-0.63-0.570.65-0.630.960.25
0.550.670.160.210.430.010.17-0.220.19-0.130.110.530.170.3-0.250.430.090.640.80.06-0.20.070.030.13-0.03-0.210.41-0.280.03
0.3-0.230.340.54-0.16-0.60.56-0.320.190.54-0.360.540.920.83-0.190.23-0.57-0.210.080.610.550.610.60.320.59-0.390.47-0.38-0.11
-0.28-0.24-0.2-0.14-0.290.14-0.180.3-0.130.54-0.220.010.290.49-0.28-0.17-0.03-0.07-0.190.030.080.030.07-0.320.05-0.01-0.160.21-0.3
-0.110.150.37-0.06-0.110.15-0.24-0.350.11-0.36-0.220.11-0.36-0.420.02-0.280.17-0.040.08-0.34-0.22-0.33-0.35-0.02-0.27-0.330.05-0.31-0.38
0.640.480.370.280.03-0.210.43-0.470.530.540.010.110.430.64-0.560.39-0.040.250.510.05-0.080.050.010.320.0-0.410.47-0.50.07
0.31-0.330.50.78-0.16-0.830.65-0.490.170.920.29-0.360.430.660.120.22-0.79-0.320.090.830.760.830.820.460.82-0.530.65-0.53-0.11
0.620.160.00.140.01-0.190.62-0.010.30.830.49-0.420.640.66-0.620.6-0.110.230.290.210.060.210.21-0.010.14-0.10.15-0.12-0.08
-0.5-0.530.40.57-0.03-0.51-0.18-0.33-0.25-0.19-0.280.02-0.560.12-0.62-0.51-0.65-0.49-0.250.620.680.620.630.280.66-0.350.39-0.28-0.09
0.930.52-0.3-0.070.250.030.720.240.430.23-0.17-0.280.390.220.6-0.510.210.50.5-0.05-0.25-0.05-0.06-0.09-0.140.040.10.170.11
0.080.62-0.67-0.90.210.93-0.390.620.09-0.57-0.030.17-0.04-0.79-0.11-0.650.210.60.17-0.92-0.97-0.92-0.94-0.47-0.960.62-0.70.640.16
0.490.88-0.28-0.350.680.6-0.110.250.64-0.21-0.07-0.040.25-0.320.23-0.490.50.60.8-0.39-0.71-0.39-0.4-0.4-0.550.22-0.180.14-0.05
0.610.830.180.190.670.110.1-0.240.80.08-0.190.080.510.090.29-0.250.50.170.80.05-0.310.060.010.06-0.1-0.250.37-0.3-0.06
0.03-0.450.60.920.0-0.890.4-0.560.060.610.03-0.340.050.830.210.62-0.05-0.92-0.390.050.921.00.990.520.98-0.560.7-0.56-0.12
-0.19-0.720.570.85-0.3-0.920.35-0.52-0.20.550.08-0.22-0.080.760.060.68-0.25-0.97-0.71-0.310.920.920.920.510.98-0.530.61-0.49-0.11
0.03-0.450.60.920.0-0.890.41-0.570.070.610.03-0.330.050.830.210.62-0.05-0.92-0.390.061.00.920.990.520.98-0.560.71-0.57-0.12
0.01-0.490.580.9-0.02-0.870.4-0.520.030.60.07-0.350.010.820.210.63-0.06-0.94-0.40.010.990.920.990.420.98-0.560.68-0.56-0.16
0.01-0.170.480.58-0.09-0.670.23-0.630.130.32-0.32-0.020.320.46-0.010.28-0.09-0.47-0.40.060.520.510.520.420.54-0.30.55-0.440.34
-0.07-0.580.610.91-0.15-0.930.39-0.57-0.030.590.05-0.270.00.820.140.66-0.14-0.96-0.55-0.10.980.980.980.980.54-0.570.69-0.56-0.11
-0.190.04-0.7-0.740.150.58-0.280.65-0.21-0.39-0.01-0.33-0.41-0.53-0.1-0.350.040.620.22-0.25-0.56-0.53-0.56-0.56-0.3-0.57-0.80.680.45
0.290.040.60.87-0.05-0.710.34-0.630.410.47-0.160.050.470.650.150.390.1-0.7-0.180.370.70.610.710.680.550.69-0.8-0.630.08
-0.160.08-0.97-0.78-0.150.66-0.280.96-0.28-0.380.21-0.31-0.5-0.53-0.12-0.280.170.640.14-0.3-0.56-0.49-0.57-0.56-0.44-0.560.68-0.630.35
0.020.15-0.39-0.12-0.070.05-0.060.250.03-0.11-0.3-0.380.07-0.11-0.08-0.090.110.16-0.05-0.06-0.12-0.11-0.12-0.160.34-0.110.450.080.35
Click cells to compare fundamentals
Competition

Cocrystal Price Earnings Ratio

Price Earnings Ratio

(0.39)

At this time, Cocrystal Pharma's Price Earnings Ratio is relatively stable compared to the past year.
Based on the latest financial disclosure, Cocrystal Pharma has a Target Price of 8.0. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The target price for all United States stocks is notably lower than that of the firm.

Cocrystal Target Price Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cocrystal Pharma's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cocrystal Pharma could also be used in its relative valuation, which is a method of valuing Cocrystal Pharma by comparing valuation metrics of similar companies.
Cocrystal Pharma is currently under evaluation in target price category among related companies.

Cocrystal Fundamentals

About Cocrystal Pharma Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cocrystal Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cocrystal Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cocrystal Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious andor chronic viral diseases. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp Dohme Corp. to discover and develop proprietary influenza AB antiviral agents a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections and drug discovery collaboration with HitGen and InterX Inc. Cocrystal Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.

Pair Trading with Cocrystal Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cocrystal Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cocrystal Stock

  0.66MBRX Moleculin Biotech Financial Report 9th of May 2024 PairCorr
  0.75MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Cocrystal Stock

  0.77MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.76EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.72CLVRW Clever Leaves HoldingsPairCorr
  0.7MDWD Mediwound Downward RallyPairCorr
The ability to find closely correlated positions to Cocrystal Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cocrystal Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cocrystal Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cocrystal Pharma to buy it.
The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cocrystal Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cocrystal Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cocrystal Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cocrystal Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Cocrystal Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Cocrystal Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Cocrystal Pharma Stock:
Check out Cocrystal Pharma Piotroski F Score and Cocrystal Pharma Altman Z Score analysis.
To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.
Note that the Cocrystal Pharma information on this page should be used as a complementary analysis to other Cocrystal Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Cocrystal Stock analysis

When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is Cocrystal Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cocrystal Pharma. If investors know Cocrystal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cocrystal Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.97)
Revenue Per Share
0.006
Quarterly Revenue Growth
0.269
Return On Assets
(0.32)
Return On Equity
(0.48)
The market value of Cocrystal Pharma is measured differently than its book value, which is the value of Cocrystal that is recorded on the company's balance sheet. Investors also form their own opinion of Cocrystal Pharma's value that differs from its market value or its book value, called intrinsic value, which is Cocrystal Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cocrystal Pharma's market value can be influenced by many factors that don't directly affect Cocrystal Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cocrystal Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cocrystal Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cocrystal Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.